Acyclovir Dosing for Bell's Palsy
Acyclovir should NOT be used as monotherapy for Bell's palsy, but if used in combination with oral steroids, the dose is 400 mg orally five times daily (total 2000 mg/day) for 10 days, initiated within 72 hours of symptom onset. 1
Critical Context: Acyclovir's Limited Role
The 2013 American Academy of Otolaryngology-Head and Neck Surgery guideline makes a strong recommendation AGAINST acyclovir monotherapy for Bell's palsy 1. High-quality randomized controlled trials demonstrate that antiviral therapy alone is no better than placebo for facial nerve recovery. The evidence is unequivocal on this point.
Combination therapy (acyclovir + steroids) is only an OPTION, not a recommendation 1. The guideline states clinicians "may offer" oral antiviral therapy in addition to oral steroids, reflecting an equilibrium of benefit and harm with only small potential improvements in facial nerve function.
Specific Dosing Regimen
Adults (16 years and older):
- Acyclovir: 400 mg orally 5 times daily (2000 mg/day total) for 10 days 1, 2, 3, 4
- Must be combined with prednisolone (50 mg daily for 10 days OR 60 mg daily for 5 days with 5-day taper)
- Treatment must begin within 72 hours of symptom onset 1
Pediatric Patients:
- No established dosing for Bell's palsy in children 1
- Children were excluded from most treatment trials
- Evidence suggests children have higher spontaneous recovery rates than adults, making treatment benefit unclear
Evidence Quality and Nuances
The evidence supporting combination therapy is mixed and of lower quality than steroid monotherapy:
The largest high-quality trial (BELLS study, n=551) found no benefit from acyclovir when added to prednisolone 5. Recovery rates at 3 months were 86.3% with prednisolone alone versus 79.7% with acyclovir-prednisolone combination.
Smaller trials with methodological limitations suggested modest benefits. One trial (n=221) found 96.5% recovery with combination therapy versus 89.7% with steroids alone 1, but these results are considered suspect due to study design issues.
A 2022 network meta-analysis suggested famciclovir may be superior to acyclovir, though confidence in these rankings was only moderate 6
Critical Timing
Treatment efficacy is time-dependent:
- Optimal window: Within 3 days of onset (100% recovery rate in some studies) 3, 4
- Acceptable window: Within 72 hours 1
- After 72 hours: Benefit becomes unclear and likely minimal
Common Pitfalls to Avoid
Never prescribe acyclovir alone - This is a strong recommendation against, based on clear evidence of no benefit 1
Don't delay steroids to add antivirals - Steroids are the proven effective treatment; if considering antivirals, they should be added to steroids, not replace them
Don't use lower doses - Studies used 2000 mg/day (400 mg × 5 doses); lower dosing has not been validated 2, 3, 4
Don't extend treatment beyond 10 days - All major trials used 10-day courses 1
Real-World Practice Patterns
Despite clear guidelines, only 51.9% of Bell's palsy patients receive the recommended steroid treatment 7. Combination therapy is prescribed in 34.1% of cases, often influenced by regional practice patterns and patient comorbidities rather than evidence-based indications.
Bottom Line Algorithm
- Diagnose Bell's palsy (exclude other causes)
- Prescribe oral steroids within 72 hours (strong recommendation)
- Consider adding acyclovir 400 mg 5×/day for 10 days (optional, equilibrium of benefit/harm)
- If acyclovir is used, ensure it's combined with steroids, never alone
- Implement eye protection for impaired eye closure (strong recommendation) 1
The weight of evidence, particularly the high-quality BELLS trial 5, suggests that adding acyclovir to steroids provides minimal to no additional benefit for most patients, making steroids alone the most evidence-based approach.